This comprehensive report provides a detailed analysis of the global targeted gene sequencers market, forecasting its trajectory from 2025 through 2032. The study examines market dynamics across various types, such as single and multi-carrier systems, and applications including scientific research, clinical medicine, and agriculture. By evaluating key players like Illumina and Thermo Fisher Scientific, the report highlights regional growth trends in the Americas, APAC, and Europe, while identifying emerging opportunities and competitive strategies shaping the industry.

Market Overview

Global Market Projections

The global Targeted Gene Sequencers market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate throughout the forecast period.

Regional Market Projections

• United States: The market for Targeted Gene Sequencers in the United States is estimated to increase from 2025 through 2032, maintaining a consistent compound annual growth rate.
• China: The market for Targeted Gene Sequencers in China is estimated to increase from 2025 through 2032, maintaining a consistent compound annual growth rate.
• Europe: The market for Targeted Gene Sequencers in Europe is estimated to increase from 2025 through 2032, maintaining a consistent compound annual growth rate.

Report Scope and Methodology

LP Information, Inc. (LPI)’s newest research report, the “Targeted Gene Sequencers Industry Forecast,” reviews total world Targeted Gene Sequencers sales in 2025 based on past sales and reviews. The report provides a comprehensive analysis by region and market sector of projected Targeted Gene Sequencers sales for the period of 2026 through 2032.

With Targeted Gene Sequencers sales broken down by region, market sector, and sub-sector, this report provides a detailed analysis of the world Targeted Gene Sequencers industry in US$ millions. This Insight Report provides a comprehensive analysis of the global Targeted Gene Sequencers landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

The report also analyzes the strategies of leading global companies with a focus on Targeted Gene Sequencers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Gene Sequencers market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Gene Sequencers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. Utilizing a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study offers a highly nuanced view of the current state and future trajectory in the global Targeted Gene Sequencers market. The report presents a comprehensive overview, market shares, and growth opportunities of the Targeted Gene Sequencers market by product type, application, key manufacturers, and key regions and countries.

Market Segmentation

By Type

• Single Carrier
• Multi-Carrier

By Application

• Scientific Research
• Clinical Medicine
• Agriculture
• Others

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

Key Players

The following companies have been profiled based on inputs gathered from primary experts and analysis of the companies' coverage, product portfolios, and market penetration:

• Thermo Fisher Scientific
• Illumina
• Pacific Biosciences
• Oxford Nanopore Technologies
• Element Biosciences
• Roche
• Mgi Tech
• GeneMind

Market Share

In terms of revenue, the global two largest companies occupied a significant portion of the market share in 2025.

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Targeted Gene Sequencers Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Targeted Gene Sequencers by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Targeted Gene Sequencers by Country/Region, 2021, 2025 & 2032

  • 2.2 Targeted Gene Sequencers Segment by Type

    • 2.2.1 Single Carrier

    • 2.2.2 Multi-Carrier

    • 2.2.3 Targeted Gene Sequencers Sales by Type

      • 2.2.3.1 Global Targeted Gene Sequencers Sales Market Share by Type (2021-2026)
      • 2.2.3.2 Global Targeted Gene Sequencers Revenue and Market Share by Type (2021-2026)
      • 2.2.3.3 Global Targeted Gene Sequencers Sale Price by Type (2021-2026)

  • 2.3 Targeted Gene Sequencers Segment by Application

    • 2.3.1 Scientific Research

    • 2.3.2 Clinical Medicine

    • 2.3.3 Agriculture

    • 2.3.4 Others

    • 2.3.5 Targeted Gene Sequencers Sales by Application

      • 2.3.5.1 Global Targeted Gene Sequencers Sale Market Share by Application (2021-2026)
      • 2.3.5.2 Global Targeted Gene Sequencers Revenue and Market Share by Application (2021-2026)
      • 2.3.5.3 Global Targeted Gene Sequencers Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Targeted Gene Sequencers Breakdown Data by Company

    • 3.1.1 Global Targeted Gene Sequencers Annual Sales by Company (2021-2026)

    • 3.1.2 Global Targeted Gene Sequencers Sales Market Share by Company (2021-2026)

  • 3.2 Global Targeted Gene Sequencers Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Targeted Gene Sequencers Revenue by Company (2021-2026)

    • 3.2.2 Global Targeted Gene Sequencers Revenue Market Share by Company (2021-2026)

  • 3.3 Global Targeted Gene Sequencers Sale Price by Company

  • 3.4 Key Manufacturers Targeted Gene Sequencers Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Targeted Gene Sequencers Product Location Distribution

    • 3.4.2 Players Targeted Gene Sequencers Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Targeted Gene Sequencers by Geographic Region

  • 4.1 World Historic Targeted Gene Sequencers Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Targeted Gene Sequencers Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Targeted Gene Sequencers Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Targeted Gene Sequencers Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Targeted Gene Sequencers Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Targeted Gene Sequencers Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Targeted Gene Sequencers Sales Growth

  • 4.4 APAC Targeted Gene Sequencers Sales Growth

  • 4.5 Europe Targeted Gene Sequencers Sales Growth

  • 4.6 Middle East & Africa Targeted Gene Sequencers Sales Growth

• 5 Americas

  • 5.1 Americas Targeted Gene Sequencers Sales by Country

    • 5.1.1 Americas Targeted Gene Sequencers Sales by Country (2021-2026)

    • 5.1.2 Americas Targeted Gene Sequencers Revenue by Country (2021-2026)

  • 5.2 Americas Targeted Gene Sequencers Sales by Type (2021-2026)

  • 5.3 Americas Targeted Gene Sequencers Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Targeted Gene Sequencers Sales by Region

    • 6.1.1 APAC Targeted Gene Sequencers Sales by Region (2021-2026)

    • 6.1.2 APAC Targeted Gene Sequencers Revenue by Region (2021-2026)

  • 6.2 APAC Targeted Gene Sequencers Sales by Type (2021-2026)

  • 6.3 APAC Targeted Gene Sequencers Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Targeted Gene Sequencers by Country

    • 7.1.1 Europe Targeted Gene Sequencers Sales by Country (2021-2026)

    • 7.1.2 Europe Targeted Gene Sequencers Revenue by Country (2021-2026)

  • 7.2 Europe Targeted Gene Sequencers Sales by Type (2021-2026)

  • 7.3 Europe Targeted Gene Sequencers Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Targeted Gene Sequencers by Country

    • 8.1.1 Middle East & Africa Targeted Gene Sequencers Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Targeted Gene Sequencers Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Targeted Gene Sequencers Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Targeted Gene Sequencers Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Targeted Gene Sequencers

  • 10.3 Manufacturing Process Analysis of Targeted Gene Sequencers

  • 10.4 Industry Chain Structure of Targeted Gene Sequencers

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Targeted Gene Sequencers Distributors

  • 11.3 Targeted Gene Sequencers Customer

• 12 World Forecast Review for Targeted Gene Sequencers by Geographic Region

  • 12.1 Global Targeted Gene Sequencers Market Size Forecast by Region

    • 12.1.1 Global Targeted Gene Sequencers Forecast by Region (2027-2032)

    • 12.1.2 Global Targeted Gene Sequencers Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Targeted Gene Sequencers Forecast by Type (2027-2032)

  • 12.7 Global Targeted Gene Sequencers Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Thermo Fisher Scientific

    • 13.1.1 Thermo Fisher Scientific Company Information

    • 13.1.2 Thermo Fisher Scientific Targeted Gene Sequencers Product Portfolios and Specifications

    • 13.1.3 Thermo Fisher Scientific Targeted Gene Sequencers Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Thermo Fisher Scientific Main Business Overview

    • 13.1.5 Thermo Fisher Scientific Latest Developments

  • 13.2 Illumina

    • 13.2.1 Illumina Company Information

    • 13.2.2 Illumina Targeted Gene Sequencers Product Portfolios and Specifications

    • 13.2.3 Illumina Targeted Gene Sequencers Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Illumina Main Business Overview

    • 13.2.5 Illumina Latest Developments

  • 13.3 Pacific Biosciences

    • 13.3.1 Pacific Biosciences Company Information

    • 13.3.2 Pacific Biosciences Targeted Gene Sequencers Product Portfolios and Specifications

    • 13.3.3 Pacific Biosciences Targeted Gene Sequencers Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Pacific Biosciences Main Business Overview

    • 13.3.5 Pacific Biosciences Latest Developments

  • 13.4 Oxford Nanopore Technologies

    • 13.4.1 Oxford Nanopore Technologies Company Information

    • 13.4.2 Oxford Nanopore Technologies Targeted Gene Sequencers Product Portfolios and Specifications

    • 13.4.3 Oxford Nanopore Technologies Targeted Gene Sequencers Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Oxford Nanopore Technologies Main Business Overview

    • 13.4.5 Oxford Nanopore Technologies Latest Developments

  • 13.5 Element Biosciences

    • 13.5.1 Element Biosciences Company Information

    • 13.5.2 Element Biosciences Targeted Gene Sequencers Product Portfolios and Specifications

    • 13.5.3 Element Biosciences Targeted Gene Sequencers Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Element Biosciences Main Business Overview

    • 13.5.5 Element Biosciences Latest Developments

  • 13.6 Roche

    • 13.6.1 Roche Company Information

    • 13.6.2 Roche Targeted Gene Sequencers Product Portfolios and Specifications

    • 13.6.3 Roche Targeted Gene Sequencers Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Roche Main Business Overview

    • 13.6.5 Roche Latest Developments

  • 13.7 Mgi Tech

    • 13.7.1 Mgi Tech Company Information

    • 13.7.2 Mgi Tech Targeted Gene Sequencers Product Portfolios and Specifications

    • 13.7.3 Mgi Tech Targeted Gene Sequencers Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Mgi Tech Main Business Overview

    • 13.7.5 Mgi Tech Latest Developments

  • 13.8 GeneMind

    • 13.8.1 GeneMind Company Information

    • 13.8.2 GeneMind Targeted Gene Sequencers Product Portfolios and Specifications

    • 13.8.3 GeneMind Targeted Gene Sequencers Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 GeneMind Main Business Overview

    • 13.8.5 GeneMind Latest Developments

• 14 Research Findings and Conclusion